Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04471233 · ClinicalTrials.gov registry record · NA

Influence of Patient Sex on Pain Control and Multimodal Analgesia in Total Knee Arthroplasty

A NA study, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
250
Enrollment target

NCT04471233: Completed NA study, sponsored by Northwell Health.

NCT04471233 is a NA study that has completed, run by Northwell Health. The registered enrollment target is 250 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04471233, a NA study, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
250 participants
Enrollment target

Study Summary

The purpose of this study is to examine the influence of sex on postoperative pain, following total knee arthroplasty (TKA). Patients will first be stratified by sex and then be randomized into one of two multimodal analgesic regimen (MAR), which differ in presence of pregabalin. We hypothesize that that acute postoperative pain scores are different over time between males and females and between multimodal analgesic regimens following TKA. Investigators will be blinded to which multimodal group patients are in. Patients will complete surveys in the office, during their hospital stay, and at followup intervals for up to six months.

Primary Outcome

Pain control measured by 100mm visual analogue scale (VAS) while at rest 48 hours after the procedure.

Interventions

  • OTHER Multimodal analgesia including pregabalin
  • OTHER Multimodal analgesia not including pregabalin

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2020-12-09
Est. Completion 2023-06-20
Phase NA
Northwell Health

370 total trials

What the finished NCT04471233 record still lists

NCT04471233 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 2 interventions - of which Multimodal analgesia including pregabalin is the first listed.

NCT04471233 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04471233 about?

NCT04471233 is a clinical study titled "Influence of Patient Sex on Pain Control and Multimodal Analgesia in Total Knee Arthroplasty". The purpose of this study is to examine the influence of sex on postoperative pain, following total knee arthroplasty (TKA). Patients will first be stratified by sex and then be randomized into one of two multimodal analgesic regimen (MAR), which differ in presence of pregabalin. We hypothesize that...

What is the current status of trial NCT04471233?

This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2020-12-09. Estimated completion is 2023-06-20.

What interventions are being tested in trial NCT04471233?

The interventions under investigation include: Multimodal analgesia including pregabalin (OTHER), Multimodal analgesia not including pregabalin (OTHER).

Who is sponsoring clinical trial NCT04471233?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04471233's enrollment target sits among peer trials

250 410th of 2000 higher than 1,567 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04471233, the US trial registry maintained by the National Library of Medicine. NCT04471233 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.